GSGTF Stock Price, Chart, Stats & News

GenSight Biologics S. A. is a clinical-stage biotechnology firm dedicated to pioneering, advancing, and bringing to market treatments for serious eye and central nervous system disorders, specifically those linked to mitochondrial dysfunction and neurodegeneration. Their therapeutic pipeline is built upon cutting-edge gene therapy approaches, including mitochondrial targeting sequences and optogenetics technologies.